<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>hodgkin's lymphoma</item><item>line</item><item>lymphoma</item><item>melanoma</item></item><item key="slug">gene-expression-profile-of-hodgkins-lymphoma-cells</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40988</item><item key="id">2631</item><item key="species">human</item><item key="name">Gene expression profile of Hodgkin&#8217;s lymphoma cells after knock-down of PRAME</item></item><item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>hodgkin's lymphoma</item><item>line</item><item>lymphoma</item></item><item key="slug">gene-expression-profile-of-hodgkins-lymphoma-cel-2</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-52831</item><item key="id">2711</item><item key="species">human</item><item key="name">Gene expression profile of Hodgkin&#8217;s lymphoma cells after knock-down of DUSP5</item></item><item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>hodgkin's lymphoma</item><item>lymphoma</item></item><item key="slug">gene-expression-profiles-of-hodgkins-lymphoma-ce-2</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26325</item><item key="id">1327</item><item key="species">human</item><item key="name">Gene expression profiles of Hodgkin&#8217;s lymphoma cell lines with different sensitivity to cytotoxic drugs</item></item><item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>histone</item><item>hodgkin's lymphoma</item><item>line</item><item>lymphoma</item></item><item key="slug">gene-expression-profiles-of-hodgkins-lymphoma-cell</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-30884</item><item key="id">1267</item><item key="species">human</item><item key="name">Gene expression profiles of Hodgkin&#8217;s lymphoma cells after treatment with vorinostat</item></item></data></biogps>
